The penny stock world is rarely boring — but heading into Monday, June 29, 2026, it is genuinely on fire. A SpaceX-linked warrant trading under a dime. A micro-cap agri-food company that went from sub-$0.20 to nearly $20 in a matter of weeks. A beaten-down biotech carrying an FDA-approved drug with a critical new billing code going live July 1. And quantum computing micro-caps surging on White House executive orders signed Monday morning. Let’s see the stock watchlist – Penny Stocks to Watch Tomorrow!
The opportunities are real. So are the landmines. Here’s the full breakdown.
Before You Trade: The Penny Stock Reality Check
Penny stocks — broadly defined as stocks trading under $5, and specifically here as those under $2 — are the highest-risk segment of the equities market. Key risks:
- Thin liquidity: Wide bid-ask spreads; difficult to exit at desired prices
- Dilution risk: Many sub-$2 companies issue shares to raise capital, destroying value
- Fundamental distress: Low prices often reflect real business challenges
- Volatility: 30–100%+ moves in a single session are common — in both directions
The rule: Never trade penny stocks without a clear catalyst, defined risk parameters, and position sizing you can afford to lose entirely. With that said — here’s what’s moving.
Penny Stock Watchlist: Monday, June 29, 2026
#1 — ILLRW (Triller Group Inc. Warrants) | The Sub-$0.10 SpaceX Derivative
Price (June 26, 2026): $0.0938 Exchange: OTC Markets / Nasdaq-listed issuer What it is: A warrant instrument linked to ILLR (Triller Group Inc.)
This is the most talked-about sub-$0.10 name right now — and the reason is extraordinary.
The Catalyst: On June 25, 2026, Triller Group announced it has entered definitive agreements to acquire $411.3 million of economic exposure to SpaceX — specifically 3,917,185 Class A SpaceX shares at $105/share equivalent — to be held as a strategic treasury asset. The deal closes by July 22, 2026.
The common stock (ILLR) exploded from sub-$0.20 to above $4.00 — a gain of more than +400% in four trading sessions. On Friday premarket, ILLR was up +64.9% on 24 million shares, with Stocktwits sentiment flipping to “extremely bullish” on “extremely high” message volume.
ILLRW (the warrant) at $0.0938 represents:
- A derivative on an already-explosive stock
- Ultra-high leverage with commensurately ultra-high risk
- Trading at a fraction of the common shares
Key ILLR/ILLRW data:
| Metric | Data |
|---|---|
| ILLRW Price | $0.0938 (June 26 close) |
| ILLR Common Price | ~$4.16–$4.63 (end of week range) |
| SpaceX acquisition price | $411.3M for 3.917M shares at $105/share |
| Deal closing deadline | July 22, 2026 |
| ILLR resistance | $4.80–$5.00 |
| ILLR support | $3.50 (below = deal doubt territory) |
| ILLR Q1 revenue | ~$5.0M (annualized ~$21.6M) |
| ILLR equity | Negative (-$349M) — distressed balance sheet |
The Triller App platform: 327 million Triller app accounts; 436 million across all platforms. CEO Wing-Fai Ng: “SpaceX is one of the most extraordinary companies of our generation.”
Monday watch: If ILLR holds above $4.00 and volume remains elevated, ILLRW could continue to reflect the common’s momentum. If the SpaceX deal faces scrutiny or ILLR breaks below $3.50, ILLRW could move toward zero quickly.
#2 — SDOT (Sadot Group Inc.) | From $0.16 to $19 — The Week’s Most Stunning Micro-Cap Move
This stock was a true penny stock just weeks ago. Understanding what happened is essential for Monday.
The Timeline:
- Pre-May 22, 2026: SDOT traded as a sub-$0.20 penny stock — one of thousands of forgotten micro-caps
- May 22, 2026: Sadot executed a 1-for-20 reverse stock split, consolidating share count
- June 1, 2026: Post-split price = ~$3.10 (equivalent to ~$0.155 pre-split)
- June 11, 2026: SDOT surged to an intraday high of ~$39.86 — a parabolic spike driven by early acquisition rumors
- June 26, 2026: Announced completion of $12M acquisition of Anira Consulting (UAE-based commodity trading firm) — stock up +89% during the session
- June 28 price: ~$19.28 (day range $8.76–$25.40)
- 52-week range (post-split): $2.63 – $460.00
The Fundamentals (Are Ugly, But That’s Not Why Traders Are Here):
- Revenue: ~$246.9M (agri-commodity trading and food service)
- Profit margin: approximately -86%
- Cash on hand: ~$679,000 — very thin cushion
- Q1 2026 net income: approximately -$4.87M
- Negative book value per share; working capital deeply negative
Why Traders Care: The Anira deal — paid via common stock, Series B preferred shares, and a $5M convertible note — expands Sadot’s commodity trading footprint into the Middle East UAE market at precisely the moment when post-Hormuz crisis commodity flows are being rerouted. It’s a narrative play on global food security disruption.
Monday Risk:
- Massive dilution from share-based acquisition payment
- Short squeeze dynamics: extreme daily swings ($8.76 low to $25.40 high in a single Saturday session reference)
- Multiple volatility trading halts (June 23, 24, and 26) — the circuit breakers have been triggering repeatedly
Trader’s Note: SDOT is no longer technically “under $2” — but understanding its trajectory is essential for penny stock traders because names like SDOT are exactly the type of stories that define the sub-$2 penny universe every week.
#3 — OMER (Omeros Corporation) | FDA-Approved Drug, European Rejection, Potential Bounce Candidate
Current Price (June 28): ~$8.67 (down from $10.72 before Friday’s collapse) 52-week range: $2.95 – $17.65 Note: OMER is above $2 currently — but its 52-week low of $2.95 shows it has been in the vicinity of penny stock territory, and Friday’s 19–25% collapse has drawn renewed attention.
Why It’s On This List: Omeros cratered Friday after Europe’s CHMP issued a negative opinion on narsoplimab (Yartemlea) for TA-TMA treatment in EU markets. The reversal brought the stock back near its lower range from earlier in 2026.
The Asymmetric Bull Case for Monday:
- U.S. FDA already approved Yartemlea in December 2025 — European setback doesn’t eliminate domestic commercial revenue
- Q1 2026 U.S. gross product sales: $11.1M; net sales: $9.9M — early commercial traction is real
- July 1, 2026 catalyst: CMS J-code for Yartemlea becomes effective Monday — this simplifies hospital billing and reimbursement across all payors, a significant operational positive that may be overshadowed by Friday’s news but remains very much in play
- NTAP approval: CMS recommended New Technology Add-On Payment status in its Inpatient Prospective Payment System rule — final rule expected August, effective October 2026
- Omeros intends to request re-examination of the CHMP opinion and an independent Ad Hoc Expert Group review
- HC Wainwright Buy rating, $33 price target = ~+280% upside from current ~$8.67
Key Levels to Watch:
- Support: $7.39 (Friday intraday low) — decisive break below opens path to low-$6 area
- Resistance: $10.52–$10.83 (pre-collapse levels) — recapture = bullish reversal signal
- Earnings: Next report August 12–13, 2026
#4 — Quantum Computing Micro-Caps | Monday’s White House Catalyst
Trump signed two executive orders Monday morning directing U.S. intelligence agencies to defend and bolster American quantum computing research. The orders signal a priority-level government push into quantum technology — exactly the kind of government validation that sends micro-cap quantum names flying.
Names to Watch (all in penny or near-penny territory):
| Ticker | Company | Market Status | Catalyst |
|---|---|---|---|
| QBTS | D-Wave Quantum Inc. | Sub-$10 range, often volatile | Trump quantum EOs; AI demand |
| RGTI | Rigetti Computing Inc. | Micro-cap quantum processor firm | White House policy tailwind |
| INFQ | Infleqtion Inc. | Neutral-atom quantum sensing | +12% previously on Trump quantum push |
Why This Matters for Monday: Quantum computing has been one of the fastest-moving speculative themes of 2026. INFQ (Infleqtion) surged +12% earlier this month specifically when Trump announced quantum policy acceleration. The executive orders signed Monday morning are an escalation of that theme — expect unusual premarket volume in QBTS and RGTI specifically, as these are the most liquid micro-cap quantum plays.
The QBTS Setup:
- D-Wave Quantum provides quantum computing services via cloud access
- Revenue model includes commercial subscriptions — more tangible than pure hardware plays
- Has appeared multiple times in quantum ETF inflows discussions
The RGTI Setup:
- Rigetti provides gate-model quantum computing cloud services
- Partnership activity increasing with tech giants in 2026
- High beta to any quantum policy news
#5 — LCID (Lucid Group Inc.) | EV Distress Play Near Historical Lows
Lucid Group — the Saudi Arabia-backed (PIF) luxury electric vehicle maker — has been one of the market’s most consistent underperformers, with shares repeatedly visiting sub-$2 territory throughout 2025–2026.
Context for Monday:
- Multiple rounds of dilutive capital raises have weighed on the stock
- Delivery numbers have improved but remain far below Tesla-scale
- The Saudi Public Investment Fund’s ongoing financial backstop provides a structural floor
- EV market headwinds persist — LCID competes in the luxury segment where demand has been pressured by rising interest rates and softening consumer sentiment
- Production at the Arizona facility continues to scale, but profitability remains years away
Key Investor Consideration: The stock’s 52-week pattern has been characterized by brief surges (often on delivery reports or production milestones) followed by declines. For traders focused on names near or at historical lows with asymmetric upside, LCID fits the profile — the Saudi PIF backing makes a zero scenario structurally unlikely.
Note to readers: Confirm LCID’s current price at your broker before trading — prices can shift materially in thin markets. Check Yahoo Finance LCID for real-time quotes.
#6 — MAAS (Maase Inc.) and SHAZ (SharonAI Holdings) | Ultra-Speculative AI Micro-Caps
These two names have appeared repeatedly in the same Yahoo Finance related-stocks lists as the week’s most volatile micro-caps. Both are in the ultra-speculative tier.
MAAS (Maase Inc.):
- Micro-cap AI-adjacent company
- Very limited publicly disclosed financial data
- The name’s appearance in high-volume penny stock screens suggests unusual activity
SHAZ (SharonAI Holdings Inc.):
- AI-focused micro-cap
- Appears alongside extremely volatile names in the current market cycle
- Essentially a pure speculative play — no established revenue or product track record that’s publicly verifiable
For both: Treat these as extreme speculation only. Position size accordingly — or avoid entirely. Names this small and illiquid can move 50–200% in a session and reverse equally fast.
🔗 Screen penny stocks daily at Finviz Stock Screener
The Penny Stock Framework for Monday
Before the opening bell, here’s what experienced penny stock traders look for:
Catalyst Check:
- Does the stock have actual news (FDA, SEC filing, acquisition, earnings, government contract)?
- Is the catalyst confirmed in an official filing or press release?
- Rumors without filings = dangerous; official 8-K filings = real
Volume Confirmation:
- Monday’s opening volume vs. the 30-day average volume — look for at least 3x average volume
- ILLRW and SDOT have both been trading at 100x+ their average volumes — extreme momentum signal
Technical Setup:
- Pre-market gap up with support: buyers are in control from the start
- Gap up without support (i.e., gap up but immediate selling): likely a fade trade
- Stocks that held most of their Friday gains over the weekend (like ILLR above $4) vs. stocks that gave back all gains overnight
Key Penny Stock Red Flags:
- Reverse stock splits without operational improvements (dilution machines)
- Share-based acquisitions with no cash component (SDOT model — requires conviction in the narrative)
- CEO shareholder letters emphasizing “transformational” deals without revenue proof
Quick Reference: Monday Penny Stock Data Table
| Ticker | Last Known Price | Catalyst | Risk Level |
|---|---|---|---|
| ILLRW | $0.0938 (June 26) | Triller/SpaceX treasury deal warrant | 🔴 Extreme |
| SDOT | ~$19.28 (June 28 ref.) | Anira UAE acquisition; food security play | 🔴 Extreme |
| OMER | ~$8.67 (June 28) | EMA rejection; J-code effective July 1 | 🟠 Very High |
| QBTS | Sub-$10 range | Trump quantum computing EOs | 🟠 Very High |
| RGTI | Sub-$10 range | White House quantum policy acceleration | 🔴 Extreme |
| LCID | Near 52-week lows | EV recovery play; Saudi PIF backing | 🟠 Very High |
| MAAS | Unknown / verify | AI micro-cap speculation | 🔴 Extreme |
| SHAZ | Unknown / verify | AI micro-cap speculation | 🔴 Extreme |
Always verify current prices before trading. Data points reflect available information as of June 26–28, 2026.
Why This Week Is Particularly Volatile for Penny Stocks
Five factors make Monday particularly high-stakes for sub-$2 names:
- Q2 ends Monday — institutional rebalancing and window-dressing creates unusual volume and price dislocations
- Holiday-shortened week — lower overall market volume amplifies moves in illiquid names
- Trump’s quantum computing EOs signed Monday — sector-specific catalyst hitting at the open
- SpaceX (SPCX) story ongoing — ILLR/ILLRW still processing the announcement; any new SPCX headline moves the trade
- Biotech binary events pending — SLS REGAL trial readout is literally “one event away” — creates heightened activity in all biotech penny names
For more penny stock tracking and market coverage, visit TruthsandNews.com
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Penny stocks and micro-cap securities carry significantly elevated risks including potential total loss of invested capital, extreme illiquidity, and susceptibility to price manipulation. Always complete independent due diligence prior to executing equity trades. Never invest in penny stocks more than you can afford to lose entirely.
Track penny stock movers at AllPennyStocks.com | Use screeners at Finviz to filter sub-$2 stocks by volume penny stocks to watch tomorrow
About The Author
